Medicines That Make a Difference®

Finding a Way

Presentations & Events

Upcoming Events

There are currently no events to display.

Presentations

Date Title Documents

Investor Presentation – September

Archived Events

Date Title
08/01/18 at
5:00 AM PDT 		Theravance Biopharma Second Quarter 2018 Earnings Results Call

Supporting Materials
05/24/18 at
9:00 AM PDT 		KOL Event – Neurogenic Orthostatic Hypotension
05/17/18 at
10:40 AM PDT 		Theravance Biopharma at the Bank of America Merrill Lynch 2018 Health Care Conference
05/08/18 at
2:00 PM PDT 		Theravance Biopharma First Quarter 2018 Earnings Results Call

Supporting Materials
03/28/18 at
9:00 AM EDT 		17th Annual Needham Healthcare Conference
02/27/18 at
2:00 PM PST 		Theravance Biopharma Fourth Quarter 2017 Earnings Results Call

Supporting Materials
02/07/18 at
8:00 AM EST 		Theravance Biopharma – Janssen Biotech, Inc. Global Collaboration Agreement for TD-1473 Analyst Call

Supporting Materials
11/29/17 at
8:45 AM EST 		Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference
11/28/17 at
8:45 AM EST 		29th Annual Piper Jaffray Healthcare Conference
11/07/17 at
5:00 PM EST 		Theravance Biopharma Third Quarter 2017 Earnings Results Call

Supporting Materials
09/26/17 at
9:10 AM EDT 		Cantor Fitzgerald Global Healthcare Conference
09/12/17 at
8:00 AM EDT 		Morgan Stanley 15th Annual Global Healthcare Conference
08/08/17 at
5:00 PM EDT 		Theravance Biopharma Second Quarter 2017 Earnings Results Call

Supporting Materials
08/02/17 at
8:00 AM EDT 		Velusetrag (TD-5108) Phase 2b Results in Gastroparesis

Supporting Materials
05/04/17 at
8:00 AM EDT 		Deutsche Bank 42nd Annual Health Care Conference
04/04/17 at
1:40 PM EDT 		16th Annual Needham Healthcare Conference
02/27/17 at
5:00 PM EST 		Theravance Biopharma Fourth Quarter 2016 Earnings Results Call
02/16/17 at
2:00 PM EST 		LEERINK Partners 6th Annual Global Healthcare Conference
11/29/16 at
10:00 AM EST 		28th Annual Piper Jaffray Healthcare Conference
11/08/16 at
5:00 PM EST 		Theravance Biopharma Third Quarter 2016 Earnings Results Call
10/20/16 at
8:00 AM EDT 		Revefenacin (TD-4208) Phase 3 Efficacy Results

Supporting Materials
09/08/16 at
2:00 PM EDT 		Baird's 2016 Healthcare Conference